Amphibian peptides that inhibit neuronal nitric oxide synthase: The isolation of lesueurin from the skin secretion of the australian stony creek frog litoria lesueuri

European Journal of Biochemistry

Volumn 269, Issue 1, 2002, Pages 100-109

  Doyle, Jason ^a   Llewellyn, Lyndon E ^a   Brinkworth, Craig S ^b   Bowie, John H ^b   Wegener, Kate L ^b   Rozek, Tomas ^b   Wabnitz, Paul A ^b   Wallace, John C ^b   Tyler, Michael J ^b  

^a AUSTRALIAN INSTITUTE OF MARINE SCIENCE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Amphibians; Ca2+calmodulin interaction; Litoria lesueuri; neuropeptides; nNOS inhibition

Indexed keywords

ANALGESIC AGENT; ARGININE; AUREIN; CAERIN; CALCINEURIN; CALCIUM ION; CALMODULIN; CERULETIDE; CITROPIN; FRENATIN; HORMONE; LESUEURIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEPTIDE; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG POTENCY; ENZYME INHIBITION; FROG; IC 50; INHIBITION KINETICS; LITORIA LESUEURI; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; PROTEIN ISOLATION; PROTEIN STRUCTURE; SKIN SECRETION; SMOOTH MUSCLE;

AMINO ACID SEQUENCE; ANIMALS; CALMODULIN; MOLECULAR SEQUENCE DATA; NEUROPEPTIDES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; RANIDAE; SKIN;

AMPHIBIA; ANIMALIA; ANURA; LITORIA; LITORIA LESUEURII;

EID: 0036151139     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0014-2956.2002.02630.x     Document Type: Article

References (75)

1. Peptides from frog skin
2. The toad, ugly and venomous, wears yet a precious jewel in his skin
3. Bioactive secretions of the amphibian integument
4. Amphibian skin: A promising resource for antimicrobial peptides
5. The structure of caerulein
6. The structures of the caerins and caeridin 1 from Litoria splendida
7. Caerulein like peptides from the skin glands of the Australian Blue Mountains tree frog Litoria citropa. Part 1. Sequence determination using electrospray mass spectrometry
8. Host defence antibacterial peptides from the skin secretions of Australian amphibians
9. Host defence peptides from the skin glands of the Australian Blue Mountains tree frog Litoria citropa. The antibacterial citropin 1 peptides. The solution structure of citropin 1.1
10. The antibiotic citropin peptides from the Australian tree frog Litoria citropa. Structure determination using electrospray mass spectrometry
11. The antibiotic and anticancer active aurein peptides from the Australian bell frogs Litoria aurea and Litoria raniformis. The solution structure of aurein 1.2
12. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines
13. The solution structure and activity of caerin 1.1, an antibiotic peptide from the Australian tree frog Litoria splendida
14. Molecular recognition between membrane-scanning peptides
15. Structure and function of channel forming peptides; magainins, cecropins, melittin and alamethicin
16. Magainins as paradigm for the mode of pore forming polypeptides
17. The structures of four tryptophyllin and three rubellidin peptides from the Australian red tree frog Litoria rubella
18. The application of mass spectrometry to the study of evolutionary trends in amphibians
19. The structures of new peptides from Litoria rubella
20. Peptides from the skin glands of the Australian buzzing tree frog Litoria electrica. Comparison with the skin peptides of Litoria rubella
21. Phyllomedusa skin: A large factory and storehouse of a variety of active peptides
22. Tryptophyllin-like immunoreactivity in rat adenohypophysis
23. A potent and selective endogenous agonist for the mu-opiate receptor
24. The structures of the dynastins from the Banjo frogs Limnodynastes interioris. L. dumerilii and L. terraereginae
25. The Structures of the dynastins and fletcherin from Limnodynastes salmini and Limnodynastes fletcheri
26. A novel method for the release and collection of dermal glandular secretions from the skin of frogs
27. Caerulein type peptides from the skin glands of the Australian Blue Mountains tree frog Litoria citropa. Part 1. Sequence determination using electrospray mass spectrometry
28. Mass spectrometric determination of the sequences of peptides and proteins
29. High sensitivity sequencing with a gas-phase sequencer
30. Larger scale multi-pinpeptide synthesis
31. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd approved standard
32. 3H]saxi-toxin binding to tetrodotoxin-resistant and - sensitive sodium channels. A two-site structural model of ion/toxin interaction
33. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase
34. Nitric oxide synthase and mechanism
35. Nitric oxide synthase: Aspects concerning structure and catalysis
36. Nitric oxide: A protective or pathogenic molecule
37. Calcium induced structural changes and domain autonomy in calmodulin
38. Identification, characterisation and comparison of the calmodulin-binding domains of nitric oxide synthases
39. Calmodulin-dependent regulation of inducible and neuronal nitric oxide synthase
40. Calmodulin activated intra-molecular transfer between the two flavins of neuronal nitric oxide synthase
41. Binding of simple peptides, hormones and neurotransmitters by calmodulin
42. Triple resonance multidimensional NMR study of calmodulin complexed with the binding domain of skeletal muscle myosin light-chain kinase: Indication of a comformational change in the central helix
43. Solution structure of a calmodulin-target peptide complex by multidimensional NMR
44. Topology of the calmodulin-melittin complex
45. 2+
46. Identification of a specific amino acid cluster in the calmodulin binding domain of nNOS
47. Sequence motifs for calmodulin recognition
48. The structure of nitric oxide synthase oxygenase domain and inhibitor complexes
49. Crystal structure of constitutive endothelial oxide synthase; A paradigm for pterin function involving a novel metal center
50. Structure of nitric oxide synthase oxygenase dimer with pterin and substrate
51. Structural characterisation of nitric oxide synthase isoforms reveals striking active-site conservation
52. Solution structure of the extended neuronal nitric oxide synthase PDZ domain complexed with an associated peptide
53. Selective inhibitors of neuronal nitric oxide synthase - Is no NOS really good NOS for the nervous system?
54. Strong inhibition of nNOS by the calmodulin antagonist and anti-estrogen drug tamoxifen
55. Structure related inhibition of calmodulin-dependent nNOS activity by melatonin and synthetic kynurenines
56. 2+ calmodulin and caveolin
57. Dissecting the interaction between NOS and caveolin
58. PIN: An associated protein inhibitor of nNOS
59. Solution structure of a protein inhibitor or neuronal nitric oxide synthase
60. Protein inhibitor of neuronal nitric oxide synthase, PIN, binds to a 17-amino acid residue fragment of the enzyme
61. Interaction of NOS with the postsynaptic density protein PSD-95 and alpha 1-syntrophin mediated by PDZ domains
62. 8caerulein and the antibiotic caerin 1.10
63. Mutational analysis of the tetrahydrobiopterin-binding site in inducible nitric oxide synthase
64. Nitric oxide in the retinotectal system: A signal but not a retrograde messenger during map refinement and segregation
65. Hormonal and cellular brain mechanism regulating amplexus of the male and female water frog Rana esculenta
66. Modulation by nitric oxide of gastric acid secretion in toads
67. Identification of NOS in Staphylococcus aureus
68. Synthesis of nitric oxide from the two equivalent guanidino nitrogens of L-arginine by Lactobacillus fermentum
69. Methylesters of L-arginine and N-nitro-L-arginine induce nitric oxide synthase in Staphyloccoccus aureus
70. Effect of NOS inhibition in experimental Pseudomonas keratitis. rabbits